Featured Press Releases

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

Mediar Therapeutics partners with Lilly to develop a first-in-class WISP1 antibody for idiopathic pulmonary fibrosis

Mediar Therapeutics partners with Lilly to develop a first-in-class WISP1 antibody for idiopathic pulmonary fibrosis

  • 10 Jan 2025

Mediar Therapeutics, Inc., a clinical stage biotechnology company advancing a portfolio of...

Nuvation Bio’s IBTROZI™ (taletrectinib), a next-generation oral treatment for advanced ROS1-positive non-small cell lung cancer, has been approved by the U.S. Food and Drug Administration

Nuvation Bio’s IBTROZI™ (taletrectinib), a next-generation oral treatment for advanced ROS1-positive non-small cell lung cancer, has been approved by the U.S. Food and Drug Administration

Prendio-BioProcure presents PrendioPay, simplifying procurement for life science companie

Prendio-BioProcure presents PrendioPay, simplifying procurement for life science companie

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

SEREMI de Salud Grants Registration to Chile

SEREMI de Salud Grants Registration to Chile's First Finished Product Featuring Setria® Glutathione

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

  • Alchemy 21/12
  • 28 Oct 2026
CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

  • CELSET INC
  • 28 Oct 2026
SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

  • SEKISUI DIAGNOSTICS, LLC
  • 27 Oct 2026
Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

  • Stevanato Group S.p.A.
  • 27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

  • Pythia Labs
  • 27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

  • Pythia Labs
  • 27 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.